Capstone Investment Advisors LLC Buys Shares of 9,289 iRhythm Technologies, Inc. (NASDAQ:IRTC)

Capstone Investment Advisors LLC bought a new stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 9,289 shares of the company’s stock, valued at approximately $1,078,000.

Several other large investors have also recently bought and sold shares of IRTC. Envestnet Asset Management Inc. raised its position in iRhythm Technologies by 112.7% in the third quarter. Envestnet Asset Management Inc. now owns 33,104 shares of the company’s stock valued at $3,120,000 after purchasing an additional 17,542 shares during the last quarter. Northern Trust Corp raised its position in iRhythm Technologies by 0.6% in the third quarter. Northern Trust Corp now owns 296,980 shares of the company’s stock valued at $27,993,000 after purchasing an additional 1,715 shares during the last quarter. O Shaughnessy Asset Management LLC bought a new position in shares of iRhythm Technologies during the third quarter worth about $379,000. Sei Investments Co. raised its position in shares of iRhythm Technologies by 1.8% during the third quarter. Sei Investments Co. now owns 226,020 shares of the company’s stock worth $21,305,000 after acquiring an additional 4,049 shares during the last quarter. Finally, Kampmann Melissa S. bought a new position in shares of iRhythm Technologies during the third quarter worth about $2,110,000.

Wall Street Analysts Forecast Growth

IRTC has been the subject of a number of analyst reports. Wolfe Research upgraded iRhythm Technologies from a “peer perform” rating to an “outperform” rating and set a $115.00 price objective for the company in a research report on Thursday, June 20th. Needham & Company LLC raised their target price on iRhythm Technologies from $137.00 to $138.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Finally, Canaccord Genuity Group decreased their target price on iRhythm Technologies from $133.00 to $122.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. One analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $131.22.

Insider Activity at iRhythm Technologies

In related news, CAO Marc W. Rosenbaum sold 510 shares of iRhythm Technologies stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $88.91, for a total transaction of $45,344.10. Following the transaction, the chief accounting officer now owns 8,174 shares of the company’s stock, valued at $726,750.34. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CMO Minang Turakhia sold 1,404 shares of iRhythm Technologies stock in a transaction on Tuesday, July 2nd. The stock was sold at an average price of $105.65, for a total transaction of $148,332.60. Following the sale, the chief marketing officer now directly owns 27,255 shares in the company, valued at $2,879,490.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Marc W. Rosenbaum sold 510 shares of iRhythm Technologies stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $88.91, for a total value of $45,344.10. Following the sale, the chief accounting officer now owns 8,174 shares in the company, valued at $726,750.34. The disclosure for this sale can be found here. Insiders have sold a total of 3,045 shares of company stock valued at $294,234 over the last 90 days. Insiders own 0.68% of the company’s stock.

iRhythm Technologies Trading Up 2.8 %

iRhythm Technologies stock traded up $2.75 during mid-day trading on Friday, reaching $99.51. The stock had a trading volume of 331,431 shares, compared to its average volume of 360,632. The company has a current ratio of 7.10, a quick ratio of 6.95 and a debt-to-equity ratio of 7.13. iRhythm Technologies, Inc. has a fifty-two week low of $70.24 and a fifty-two week high of $124.11. The stock’s 50-day simple moving average is $97.52 and its 200-day simple moving average is $106.87.

iRhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings data on Thursday, May 2nd. The company reported ($1.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.99) by ($0.48). The firm had revenue of $131.93 million during the quarter, compared to analyst estimates of $128.87 million. iRhythm Technologies had a negative net margin of 25.33% and a negative return on equity of 69.87%. Equities research analysts forecast that iRhythm Technologies, Inc. will post -3.22 EPS for the current year.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.